Dextroamphetamine and amphetamine pharmacology
Pro Research Analysisby 
Searched over 200M research papers
Mechanism of Action: Dextroamphetamine and Amphetamine Pharmacology
Dextroamphetamine and amphetamine are central nervous system (CNS) stimulants that primarily work by increasing the release of catecholamines, especially dopamine and noradrenaline, from nerve terminals in the brain. They also inhibit the reuptake of these neurotransmitters, particularly within the mesocorticolimbic system, which is a key part of the brain's reward pathway. This dual action leads to increased neurotransmitter levels in the synaptic cleft, resulting in effects such as heightened alertness, euphoria, excitement, and appetite suppression. These stimulants can also increase blood pressure as a side effect of their sympathomimetic activity 67.
Clinical Uses and Efficacy: ADHD, Depression, and Sleep Disorders
Dextroamphetamine and amphetamine are considered the gold standard for treating attention-deficit/hyperactivity disorder (ADHD), improving cognitive and behavioral control, and enhancing the ability to implement therapeutic skills in patients with comorbid conditions like borderline personality disorder (BPD) . They have also been used as adjuncts in treatment-resistant depression, where they may provide significant symptom relief when other treatments have failed . In sleep disorders such as idiopathic hypersomnia and narcolepsy type 2, amphetamine-dextroamphetamine has shown similar efficacy to modafinil in improving cognitive symptoms and sleep inertia, though it may be less effective for reducing sleepiness as measured by the Epworth Sleepiness Scale .
Use in Substance Use Disorders: Craving and Withdrawal
Dextroamphetamine has been explored as a pharmacological intervention for stimulant use disorders, including methamphetamine and cocaine dependence. While it may not significantly reduce the use of methamphetamine, it has been shown to lower withdrawal and craving scores, suggesting potential benefits in managing symptoms of dependence . Patients receiving dextroamphetamine for stimulant use disorder report that the medication can provide a substitution effect for illicit stimulants, with effectiveness influenced by reaching a preferred dose and ease of medication access 35.
Safety, Toxicity, and Abuse Potential
The toxic effects of dextroamphetamine and amphetamine are similar to those of other stimulants, with common adverse effects including agitation and tachycardia. Most exposures result in no or minor toxicity, but serious outcomes can occur in about 21–25% of cases. Abuse and misuse are more frequently reported with immediate-release formulations compared to prodrugs like lisdexamfetamine, which may have a lower abuse potential due to its need for enzymatic conversion to the active form . Like other amphetamines, dextroamphetamine carries a high risk of abuse, dependence, and addiction, especially with prolonged or high-dose use .
Neuropsychiatric Effects: Amygdala Activation and Emotional Response
Dextroamphetamine can modulate emotional processing in the brain. It has been shown to potentiate the response of the amygdala, a region involved in processing fear and threat, during exposure to angry and fearful facial expressions. This neural activation may underlie the anxiogenic (anxiety-producing) effects sometimes observed with amphetamine use .
Conclusion
Dextroamphetamine and amphetamine are potent CNS stimulants with well-established roles in treating ADHD, certain sleep disorders, and, in some cases, treatment-resistant depression. They act by increasing dopamine and noradrenaline levels in the brain, leading to enhanced alertness and mood. While effective for several conditions, these drugs carry risks of abuse, dependence, and neuropsychiatric side effects, necessitating careful clinical management and monitoring. Their use in substance use disorders and other psychiatric conditions continues to be an area of active research and clinical interest 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic
Exploring the effectiveness of dextroamphetamine for the treatment of stimulant use disorder: a qualitative study with injectable opioid agonist treatment patients
Dextroamphetamine is effective for treating stimulant use disorder, as patients perceive it as a substitution for illicit stimulants, easy to access, and able to reach preferred doses.
DOI